MK0686 in Postsurgery Dental Pain (0686-002)

Phase 2CompletedNCT00533403

Merck Sharp & Dohme LLC114 enrolled

Overview

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

114

Conditions

Pain, Postoperative

Interventions

MK0686DRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed * Patients must agree to remain in the clinic for 24 hours after surgery Exclusion Criteria: * Patient has history of heart disease, asthma, pulmonary disease * Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.